Ads
-
Related paper
- The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
- Correction of Dyslipidemia in Patients with Coronary Heart Disease Combined with Nonalcoholic Fatty Liver Disease
- The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
- Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of secondary prevention
- Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
- Statistical Neural Networks in the Classification of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease
- Peculiarities of Gout Progression in Patients with Nonalcoholic Fatty Liver Disease
- Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetic patients in correlation with coronary artery disease
- TELMISARTAN PLUS ATORVASTATIN INFLUENCE ON ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
- Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension